| Name | Title | Contact Details |
|---|---|---|
Shobhna Asthana |
Chief Financial Officer | Profile |
Craig Mansfield |
SVP - Marketing Services | Profile |
Intrigma is a leader in medical scheduling solutions that deliver bottom-line impact to medical groups, hospitals and hospital systems.
Steadman Hawkins Sports Medicine Foundation is a Vail, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Virginia Health Care Association is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Keller Medical Communications is a Newburyport, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.